In a study of risk factors for uterine cancer, prior use of the pill was associated with a marked reduction in risk among women having a prior endometrial sampling-
We observed that OCP use before the benign endometrial biopsy or D&C was associated with more than six times lower likelihood of endometrial cancer. Similar findings in the general population were reported by othe investigators. Estimated protection with use of OCPs ranged from 20% with 1 year of use to 80% with 10 years of use.
This protective effect of OCPs against uterine cancer is not news to us docs, but bears repeating for the public. Between the recalls, the FDA rulings and the lawyers, women rarely hear anything good about the pill.